Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03714191 · ClinicalTrials.gov registry record
Optimizing the Tobacco Cessation Clinical Decision Support Tool.
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 54,417
- Enrollment target
NCT03714191 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 54,417 participants.
The verdict
NCT03714191 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 54,417 participants
- Enrollment target
Study Summary
The existing tobacco cessation best practice advisory (BPA) fires for providers (physicians, residents, fellows, midwives, nurse practitioners, physician assistants) during outpatient encounters when a patient is identified as a current tobacco user in the Social History section of their chart. The BPA was designed to help facilitate tobacco cessation interventions; it is part of the The Centers for Medicare \& Medicaid Services (CMS) Quality Payment Program (QPP). The purpose of the project is to optimize this BPA utilization and improve patient outcomes by comparing multiple versions of the tobacco cessation BPA.
Interventions
- OTHER Patient Outcomes
- OTHER Billing documentation
- OTHER Regulatory
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54,417 participants |
| Start Date | 2018-10-03 |
| Est. Completion | 2020-02-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03714191
The ClinicalTrials.gov registry entry for NCT03714191 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54,417 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Patient Outcomes is the first listed.
NCT03714191 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03714191 about?
NCT03714191 is a clinical study titled "Optimizing the Tobacco Cessation Clinical Decision Support Tool.". The existing tobacco cessation best practice advisory (BPA) fires for providers (physicians, residents, fellows, midwives, nurse practitioners, physician assistants) during outpatient encounters when a patient is identified as a current tobacco user in the Social History section of their chart. The ...
What is the current status of trial NCT03714191?
This trial is currently completed. The enrollment target is 54,417 participants. The study started on 2018-10-03. Estimated completion is 2020-02-29.
What interventions are being tested in trial NCT03714191?
The interventions under investigation include: Patient Outcomes (OTHER), Billing documentation (OTHER), Regulatory (OTHER).
Who is sponsoring clinical trial NCT03714191?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.